or Try an Advanced Search...

    Treatment Of Infectious Diseases Stocks List

    Symbol Grade Name % Change
    UTHR A United Therapeutics Corporation 1.17
    SXTP F 60 Degrees Pharmaceuticals, Inc. -3.73
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Infectious Diseases Alcohol Biotechnology Blastoma Brain Cancer Candidiasis Chemical Compounds Chronic And Life Threatening Conditions Covid 19 Dengue Dengue Fever Epidemiology Hepatitis C Hypertension Infection Lung Diseases Malaria Neuroblastoma Oral Therapy Organic Compounds

    Related ETFs - A few ETFs which own one or more of the above listed Treatment Of Infectious Diseases stocks.

    Symbol Grade Name Weight
    PJP B PowerShares Dynamic Pharmaceuticals 4.08
    FTXH C First Trust Nasdaq Pharmaceuticals ETF 3.58
    FBT D First Trust Amex Biotech Index Fund 3.38
    KONG D Formidable Fortress ETF 3.16
    PBE C PowerShares Dynamic Biotech & Genome 3.12
    View all Treatment Of Infectious Diseases ETFs...
    Compare ETFs
    Compare FBT to PBE Compare PJP to KONG Compare PJP to PBE

        Treatment Of Infectious Diseases Stocks Recent News

        Date Stock Title
        May 2 UTHR United Therapeutics (UTHR) Q1 Earnings Top, Tyvaso Drives Sales
        May 2 UTHR United Therapeutics Corporation (NASDAQ:UTHR) Q1 2024 Earnings Call Transcript
        May 2 SXTP 60 Degrees Pharmaceuticals Receives FDA Comments on Tafenoquine-Babesiosis Clinical Trial Protocol; No Material Changes Required
        May 2 UTHR United Therapeutics Corp (UTHR) Q1 2024 Earnings Call Transcript Highlights: Record Revenue and ...
        May 2 UTHR Q1 2024 United Therapeutics Corp Earnings Call
        May 1 UTHR Lung Disease-Focused United Therapeutics Says It Is A Compelling Investment Opportunity
        May 1 UTHR United Therapeutics Corporation (UTHR) Q1 2024 Earnings Call Transcript
        May 1 UTHR Compared to Estimates, United Therapeutics (UTHR) Q1 Earnings: A Look at Key Metrics
        May 1 UTHR United Therapeutics Surpasses Analyst Revenue Forecasts with Strong Q1 2024 Performance
        May 1 UTHR United Therapeutics GAAP EPS of $6.17 beats by $0.51, revenue of $677.7M beats by $53.51M
        May 1 UTHR United Therapeutics Corporation Reports First Quarter 2024 Financial Results
        Apr 30 UTHR United Therapeutics Q1 2024 Earnings Preview
        Apr 29 UTHR What Makes United Therapeutics (UTHR) a New Buy Stock
        Related Industries: Biotechnology
        Related Stock Lists: Infectious Diseases Alcohol Biotechnology Blastoma Brain Cancer Candidiasis Chemical Compounds Chronic And Life Threatening Conditions Covid 19 Dengue Dengue Fever Epidemiology Hepatitis C Hypertension Infection Lung Diseases Malaria Neuroblastoma Oral Therapy Organic Compounds
        Treatment Of Infectious Diseases

        Browse All Tags